“…This can be visualized either in the form of a reactive gel, in the instance of OxiSperm ® II (Madrid, Spain), or through their presence in sperm/leucocytes under bright-field microscopy (OxiSperm ® ), making the test quick and easy, requiring only basic laboratory equipment such as a light microscope. Many of the large cohort studies assessing the utility of OxiSperm or the NBT assay in male infertility diagnosis have only assessed infertile men, with indicators for medium to high levels of ROS present in 31–76% of infertile participants [ 53 , 54 , 58 , 59 ]. When comparing OxiSperm ® to a wide range of clinical sperm DNA damage markers (including, TUNEL, Comet, SCSA and chromatin dispersion assay) in 50 fertile and 50 infertile men, Javod et al found that OxiSperm ® had one of the highest levels of sensitivity, at 0.991, however, it had the lowest levels of specificity, at 0.322 and did not correlate with male infertility.…”